home / stock / asnd / asnd news


ASND News and Press, Ascendis Pharma A/S From 01/09/26

Stock Information

Company Name: Ascendis Pharma A/S
Stock Symbol: ASND
Market: NASDAQ
Website: ascendispharma.com

Menu

Get ASND Alerts

News, Short Squeeze, Breakout and More Instantly...

ASND - Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference

COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones. Ascendis President and CEO Jan Mikkelsen will present this update on Monday, January 12, during the 44...

ASND - Ascendis Pharma A/S (ASND) Discusses Week 52 Topline Results From COACH Trial Evaluating TransCon CNP and Growth Hormone in Achondroplasia Transcript

2026-01-08 22:34:48 ET Ascendis Pharma A/S (ASND) Discusses Week 52 Topline Results From COACH Trial Evaluating TransCon CNP and Growth Hormone in Achondroplasia January 8, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Ascendis Pharma A/...

ASND - Week 52 COACH Trial Topline Results Confirm Consistent and Durable Treatment Benefits in Children with Achondroplasia (ACH)

– Once-weekly TransCon ® CNP and TransCon ® hGH combination therapy showed durable growth without compromising safety or tolerability at 52 weeks – Annualized growth velocity (AGV) exceeded the 97th-percentile of average stature children – ACH hei...

ASND - Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference

COPENHAGEN, Denmark, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in the 44 th Annual J.P. Morgan Healthcare Conference and provide a business update on Monday, January 12, 2026, at 10:30 a.m. Eastern Time / 7:30 a....

ASND - BridgeBio Has More Room To Run

2025-12-23 12:41:26 ET Shares of BridgeBio ( BBIO ) have appreciated considerably this year. The stock has more than doubled since my first public article November 2024 and is up more than 160% since my February update . BridgeBio was one of my Top Picks in the Growth St...

ASND - BioMarin: Amicus Buyout Sparks My Enthusiasm

2025-12-22 15:15:19 ET BioMarin Pharmaceutical ( BMRN ) is my favorite in the rare disease therapeutics market thanks to Voxzogo, Palynziq, and Brineura.... Read the full article on Seeking Alpha For further details see: BioMarin: Amicus Buyout Sparks My Enthusiasm

ASND - US Companies Moving the Markets, Morning edition
Mon, Dec 15, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 14.6% to $3.29 on volume of 531,992,985 shares Paranovus Entertainment Technology Ltd. (PAVS) rose 19.1% to $0.0411 on volume of 516,994,438 shares Oriental Culture Holding LTD (OC...

ASND - Here's My Prediction For Who Could Acquire Ascendis Pharma

2025-12-15 03:18:34 ET Thesis Ascendis Pharma ( ASND ) has stirred up quite the talk with news appearing that the company may be acquired in the near term. They had pretty strong 3Q25 earnings back in November, which saw quite a bit of positive movement for the stock. Their ...

ASND - US Companies Moving the Markets, Evening edition
Fri, Dec 12, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 16.7% to $0.04025 on volume of 473,890,312 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 14.3% to $3.2805 on volume of 472,166,357 shares cbdMD Inc. (YCBD) rose 72.8% ...

ASND - Ascendis Pharma gains amid takeover speculation

2025-12-12 15:24:38 ET More on Ascendis Pharma Ascendis: Q3 Results Validate The TransCon Platform Ascendis Pharma A/S (ASND) Q3 2025 Earnings Call Transcript Ascendis dwarfism drug candidate review extended by FDA Ascendis Pharma GAAP EPS of - €1.00, ...

Previous 10 Next 10